about
Gender and age differences in systemic lupus erythematosus. A study of 489 Greek patients with a review of the literature.Age-related differences of bone mass, geometry, and strength in treatment-naïve postmenopausal women. A tibia pQCT study.CT features of gastric lymphoma.Increased benefit of interleukin-1 inhibition on vascular function, myocardial deformation, and twisting in patients with coronary artery disease and coexisting rheumatoid arthritis.No association of psoriasis with autoimmune thyroiditis.Prevalence of psoriatic arthritis and its correlates among patients with psoriasis in Greece: results from a large retrospective study.Outcome of lupus pregnancy: a controlled study.Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis.Dysphagia Caused by Chronic Laryngeal Edema.Association of soluble apoptotic markers with impaired left ventricular deformation in patients with rheumatoid arthritis. Effects of inhibition of interleukin-1 activity by anakinra.Successful treatment of life-threatening autoimmune haemolytic anaemia with ofatumumab in a patient with systemic lupus erythematosus.Early rheumatoid arthritis patients: relationship of agePrevention of chemotherapy-induced alopecia using an effective scalp cooling systemClinical course and outcome of early rheumatoid arthritisChurg-Strauss syndrome masquerading as an acute coronary syndromeThe biology of normal bone remodellingDifferential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular functionImaging Risk in Multisystem Inflammatory DiseasesReal world data from the use of secukinumab in the treatment of moderate-to-severe psoriasis, including scalp and palmoplantar psoriasis: A 104-week clinical study
P50
Q33345614-AA7167DC-A44F-4FA2-8C4C-10FCF159C8B5Q33812363-AE827128-8C2F-406D-9D7A-837D0BF61B2AQ33886442-D1604C57-43CC-4BBC-9A70-C426C4A453DDQ38431248-FA1EC12D-82CE-4BAE-BA53-FE40630DCAE4Q39669246-928171F9-87CE-421E-A1F0-00374553E721Q40533508-B3415FE9-5123-4C28-9704-EBF7FB4E9326Q40615165-4051E229-FDD5-44C4-AC1F-5AC552E285ABQ45989311-5CAEBA44-EC99-4289-A2BB-360379095B72Q47679798-4440B2ED-95EC-40E9-8124-88A3D81B3DF8Q50672550-2E042F75-193A-4BD7-8B1F-366447EDD6A9Q53762050-8103CBCF-1AC4-4463-B443-941321E06C69Q73121286-0BE01406-16C0-4D85-8B27-07470B67D53AQ73670875-07B6C5BD-6C25-4906-9F4C-D40ACE02917DQ74413835-B7EFB9EA-D70B-4D86-96AD-27F65250D59BQ85231079-C97B6785-57A6-4D9E-B092-C62290386074Q88716373-3D589DDD-1056-458A-8B2A-4A7858B17648Q92288594-04AE6726-6F3B-4253-A5E5-74FC20413265Q92411419-2279A867-612F-487B-B1BC-33F0D603B3CEQ92952581-4A18F64A-4825-416E-B14A-AB538B5EF87A
P50
description
researcher
@en
wetenschapper
@nl
name
Pelagia Katsimbri
@en
Pelagia Katsimbri
@nl
type
label
Pelagia Katsimbri
@en
Pelagia Katsimbri
@nl
prefLabel
Pelagia Katsimbri
@en
Pelagia Katsimbri
@nl
P106
P31
P496
0000-0002-7634-6863